prov:value
| - A pharmaceutical composition for the treatment and/or prevention of depression according to the claim 1, wherein EP1 antagonist is N-arylsulfonylamide compound of formula (IK) wherein R1K is COOH, hydroxymethyl, 5-tetrazolyl, 5-oxo-1,2,4-oxadiazolyl or 5-oxo-1,2,4-thiadiazolyl, R2K is hydrogen, methyl, methoxy or chloro, R3K and R4K are a combination of (1) methyl and methyl, (2) methyl and chloro
|